Related News
Australia approves roll out of H1N1 flu vaccine
AUSTRALIAN health authorities approved a vaccine for H1N1 influenza, which will be rolled out across the country from September, Health Minister Nicola Roxon said today.
"There is going to be sufficient vaccine for everyone," Roxon told reporters in Canberra, adding Australia would be one of the first countries to protect its population from the H1N1 virus.
Australia has ordered 21 million doses of the vaccine from pharmaceutical company CSL Ltd.
While the country is coming to the end of its regular flu season, chief medical officer Jim Bishop said the virus was unpredictable, and new cases could emerge throughout the summer with a possible second outbreak before the next flu season.
More than 4,600 Australians have been hospitalised and 172 people have died from H1N1 flu.
Roxon said the rollout would be Australia's biggest mass vaccination. The vaccinations will be voluntary, and Roxon said she expected the vaccine rollout to be complete by late December.
The initial vaccinations would target health workers and those most vulnerable to severe effects from the pandemic influenza, including pregnant women, people with chronic health conditions and Aborigines in remote communities.
Roxon said the full cost of the vaccines was confidential, but said it was worth more than A$100 million (US$87 million).
"There is going to be sufficient vaccine for everyone," Roxon told reporters in Canberra, adding Australia would be one of the first countries to protect its population from the H1N1 virus.
Australia has ordered 21 million doses of the vaccine from pharmaceutical company CSL Ltd.
While the country is coming to the end of its regular flu season, chief medical officer Jim Bishop said the virus was unpredictable, and new cases could emerge throughout the summer with a possible second outbreak before the next flu season.
More than 4,600 Australians have been hospitalised and 172 people have died from H1N1 flu.
Roxon said the rollout would be Australia's biggest mass vaccination. The vaccinations will be voluntary, and Roxon said she expected the vaccine rollout to be complete by late December.
The initial vaccinations would target health workers and those most vulnerable to severe effects from the pandemic influenza, including pregnant women, people with chronic health conditions and Aborigines in remote communities.
Roxon said the full cost of the vaccines was confidential, but said it was worth more than A$100 million (US$87 million).
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.